Literature DB >> 17312280

Experts weigh in on promotion, prescription of off-label drugs.

Tracy Hampton.   

Abstract

Mesh：

Year:  2007        PMID： 17312280     DOI： 10.1001/jama.297.7.683

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  11 in total

Review 1.  [Off-label therapy: current problems from the perspective of the Pharmaceutical Commission of the German Medical Profession].

Authors:  R W C Janzen; W D Ludwig
Journal:  Z Rheumatol       Date:  2012-02       Impact factor: 1.372

2.  Off-label use of atypical antipsychotics: cause for concern?

Authors:  Andrew McKean; Erik Monasterio
Journal:  CNS Drugs       Date:  2012-05-01       Impact factor: 5.749

3.  Risk management policy and black-box warnings: a qualitative analysis of US FDA proceedings.

Authors:  Daniel M Cook; Rama K Gurugubelli; Lisa A Bero
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

4.  Off-label drug information: regulation, distribution, evaluation, and related controversies.

Authors:  C Lee Ventola
Journal:  P T       Date:  2009-08

5.  Available evidence and outcome of off-label use of rituximab in clinical practice.

Authors:  I Danés; A Agustí; A Vallano; J Martínez; C Alerany; A Ferrer; A López; J Cortés-Hernández; J A Bosch
Journal:  Eur J Clin Pharmacol       Date:  2013-05-23       Impact factor: 2.953

6.  Off-label prescribing: a call for heightened professional and government oversight.

Authors:  Rebecca Dresser; Joel Frader
Journal:  J Law Med Ethics       Date:  2009       Impact factor: 1.718

7.  Unsupported off-label chemotherapy in metastatic colon cancer.

Authors:  Jonas A de Souza; Blase Polite; Monica Perkins; Neal J Meropol; Mark J Ratain; Lee N Newcomer; G Caleb Alexander
Journal:  BMC Health Serv Res       Date:  2012-12-29       Impact factor: 2.655

8.  Off-label promotion, on-target sales.

Authors:  Adriane Fugh-Berman; Douglas Melnick
Journal:  PLoS Med       Date:  2008-10-28       Impact factor: 11.069

Review 9.  Regulating off-label drug use in India: The arena for concern.

Authors:  Sukhvinder Singh Oberoi
Journal:  Perspect Clin Res       Date:  2015 Jul-Sep

10.  Outcomes of off-label drug uses in hospitals: a multicentric prospective study.

Authors:  I Danés; A Agustí; A Vallano; C Alerany; J Martínez; J A Bosch; A Ferrer; L Gratacós; A Pérez; M Olmo; S M Cano Marron; A Valderrama; X Bonafont
Journal:  Eur J Clin Pharmacol       Date:  2014-09-09       Impact factor: 2.953
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.